Brain AVM compactness score in children with hereditary hemorrhagic telangiectasia.
Angiography
Brain arteriovenous malformation
Hereditary hemorrhagic telangiectasia
Journal
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
ISSN: 1433-0350
Titre abrégé: Childs Nerv Syst
Pays: Germany
ID NLM: 8503227
Informations de publication
Date de publication:
22 Mar 2024
22 Mar 2024
Historique:
received:
07
11
2023
accepted:
14
03
2024
medline:
22
3
2024
pubmed:
22
3
2024
entrez:
22
3
2024
Statut:
aheadofprint
Résumé
The brain arteriovenous malformation (BAVM) nidus compactness score (CS), determined on angiography, predicts BAVM recurrence after surgical resection among children with sporadic BAVMs. We measured the angiographic CS for BAVMs among children with hereditary hemorrhagic telangiectasia (HHT) to determine CS characteristics in this population. A pediatric interventional neuroradiologist reviewed angiograms to determine the CS of BAVMs in children with HHT recruited to the BVMC. CS is based on overall nidus and perinidal anomalous vessel compactness. CS categories included 1 = diffuse nidus, 2 = intermediate nidus, and 3 = compact nidus. Forty-eight of 78 children (61.5%) with HHT and brain vascular malformations had a conventional angiogram; 47 (97.9%) angiograms were available. Fifty-four BAVMs were identified in 40 of these 47 children (85.1%). Of 54 BAVMs in children with HHT, CS was 1 in 7 (13%), 2 in 29 (53.7%), and 3 in 18 BAVMs (33.3%) compared with CS of 1 in six (26.1%), 2 in 15 (65.2%), and 3 in 2 BAVMs (8.7%) among 23 previously reported children with sporadic BAVMs, p = 0.045 (Fisher's exact). Seven children with HHT had intracranial hemorrhage: 4 had CS = 3, 1 had CS = 2, and 2 had CS = 1. A range of CSs exists across HHT BAVMs, suggesting it may be an angiographic measure of interest for future studies of BAVM recurrence and hemorrhage risk. Children with HHT may have more compact niduses compared to children with sporadic BAVMs. Additional research should determine whether CS affects hemorrhage risk or post-surgical recurrence risk in HHT-associated BAVMs, which could be used to direct BAVM treatment.
Identifiants
pubmed: 38517485
doi: 10.1007/s00381-024-06366-z
pii: 10.1007/s00381-024-06366-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIH HHS
ID : U54NS065705
Pays : United States
Organisme : NIH HHS
ID : U54NS065705
Pays : United States
Organisme : NIH HHS
ID : U54NS065705
Pays : United States
Organisme : NIH HHS
ID : U54NS065705
Pays : United States
Organisme : NIH HHS
ID : U54NS065705
Pays : United States
Organisme : NIH HHS
ID : U54NS065705
Pays : United States
Organisme : NIH HHS
ID : U54NS065705
Pays : United States
Organisme : NIH HHS
ID : U54NS065705
Pays : United States
Organisme : NIH HHS
ID : U54NS065705
Pays : United States
Organisme : NIH HHS
ID : U54NS065705
Pays : United States
Organisme : NIH HHS
ID : U54NS065705
Pays : United States
Organisme : NIH HHS
ID : U54NS065705
Pays : United States
Organisme : NIH HHS
ID : U54NS065705
Pays : United States
Investigateurs
Mary E Atherton
(ME)
Murali M Chakinala
(MM)
Marianne S Clancy
(MS)
Marie E Faughnan
(ME)
James R Gossage
(JR)
Adrienne M Hammill
(AM)
Katharine Henderson
(K)
Steven Hetts
(S)
Peter Hountras
(P)
Vivek Iyer
(V)
Raj S Kasthuri
(RS)
Helen Kim
(H)
Timo Krings
(T)
Michael T Lawton
(MT)
Doris Lin
(D)
Johannes Jurgen Mager
(JJ)
Douglas A Marchuk
(DA)
Justin P McWilliams
(JP)
Jamie McDonald
(J)
Ludmila Pawlikowska
(L)
Jeffrey Pollak
(J)
Felix Ratjen
(F)
Karen Swanson
(K)
Dilini Vethanayagam
(D)
Shantel Weinsheimer
(S)
Andrew J White
(AJ)
Pearce Wilcox
(P)
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Brinjikji W, Iyer VN, Wood CP, Lanzino G (2017) Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis. J Neurosurg 127(2):302–310
doi: 10.3171/2016.7.JNS16847
pubmed: 27767404
Kilian A, Latino GA, White AJ et al (2023) Comparing characteristics and treatment of brain vascular malformations in children and adults with HHT. J Clin Med 12(7):2704
doi: 10.3390/jcm12072704
pubmed: 37048789
pmcid: 10094792
Willemse RB, Mager JJ, Westermann CJ, Overtoom TT, Mauser H, Wolbers JG (2000) Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg 92(5):779–784
doi: 10.3171/jns.2000.92.5.0779
pubmed: 10794291
Kim H, Nelson J, Krings T et al (2015) Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia. Stroke 46:1362–1364
doi: 10.1161/STROKEAHA.114.007367
pubmed: 25858236
pmcid: 4415515
Easey AJ, Wallace GMF, Hughes JMB, Jackson JE, Taylor WJ, Shovlin CL (2003) Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22 061 years of HHT patient life. J Neurol Neurosurg Psychiatry 74:743–748
doi: 10.1136/jnnp.74.6.743
pubmed: 12754343
pmcid: 1738468
Rutledge WC, Ko NU, Lawton MT, Kim H (2014) Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations. Transl Stroke Res 5(5):538–542
doi: 10.1007/s12975-014-0351-0
pubmed: 24930128
pmcid: 4139097
Lang SS, Beslow LA, Bailey RL et al (2012) Follow-up imaging to detect recurrence of surgically treated pediatric arteriovenous malformations. J Neurosurg Pediatr 9(5):497–504
doi: 10.3171/2012.1.PEDS11453
pubmed: 22546027
pmcid: 3484378
Frisoli FA, Lang SS, Vossough A et al (2013) Intrarater and interrater reliability of the pediatric arteriovenous malformation compactness score in children. J Neurosurg Pediatr 11(5):547–551
doi: 10.3171/2013.2.PEDS12465
pubmed: 23495808
pmcid: 3644017
Pawlikowska L, Nelson J, Guo DE et al (2015) The ACVRL1 c.314–35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations. Am J Med Genet A 167(6):1262–7
doi: 10.1002/ajmg.a.36936
pubmed: 25847705
pmcid: 4449292
Akers AL, Ball KL, Clancy M et al (2013) Brain vascular malformation consortium: overview, progress and future directions. J Rare Disord 1(1):5
pubmed: 25221778
pmcid: 4160161
Spetzler RF, Martin NA (1986) A proposed grading system for arteriovenous malformations. J Neurosurg 65(4):476–483
doi: 10.3171/jns.1986.65.4.0476
pubmed: 3760956
Krings T, Kim H, Power S, Nelson J, Faughnan ME, Young WL, terBrugge KG, the Brain Vascular Malformation Consortium HHT Investigator Group (2015) Neurovascular manifestations in hereditary hemorrhagic telangiectasia: imaging features and genotype-phenotype correlations. Am J Neuroradiol 36:863–870
doi: 10.3174/ajnr.A4210
pubmed: 25572952
pmcid: 4433843
Bharatha A, Faughnan ME, Kim H, Pourmohamad T, Krings T, Bayrak-Toydemir P et al (2012) Brain arteriovenous malformation multiplicity predicts the diagnosis of hereditary hemorrhagic telangiectasia: quantitative assessment. Stroke 43:72–78
doi: 10.1161/STROKEAHA.111.629865
pubmed: 22034007
Yusuf H, Rasheed A, Kim H, Conrad MB, Hetts SW (2022) Identifying racial disparities in hereditary hemorrhagic telangiectasia. J NeuroIntervent Surg 0:1–6. https://doi.org/10.1136/neurintsurg-2022-019162
doi: 10.1136/neurintsurg-2022-019162